Future Prospects | Analyst price targets average $265, with STERIS projecting 6.5-7.5% revenue growth and adjusted EPS of $9.05-$9.25 for fiscal year 2025 |
Strategic Realignment | Learn about STERIS's $800 million Dental segment divestiture, aimed at streamlining operations and focusing on core healthcare businesses |
Financial Resilience | Delve into STERIS's robust financial performance, surpassing analyst expectations with impressive revenue growth and improved profitability |
Healthcare Dominance | Explore STERIS's strong market position in infection prevention and healthcare products, driving consistent organic growth in a crucial secto |
STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
Metrics to compare | STE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSTEPeersSector | |
---|---|---|---|---|
P/E Ratio | 40.6x | 143.1x | −0.6x | |
PEG Ratio | 0.17 | 1.18 | 0.00 | |
Price / Book | 3.6x | 0.8x | 2.6x | |
Price / LTM Sales | 4.4x | 1.5x | 3.2x | |
Upside (Analyst Target) | 4.1% | 9.9% | 41.1% | |
Fair Value Upside | Unlock | 38.4% | 5.9% | Unlock |